Roflumilast (Daliresp): A Novel Phosphodiesterase-4 Inhibitor for the Treatment Of Severe Chronic Obstructive Pulmonary Disease

Lignende værker

• Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
  af: Rabe, Klaus F
  Udgivet: (2011)
• Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
  af: Chong, Jimmy, et al.
  Udgivet: (2017)
• Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
  af: Janjua, Sadia, et al.
  Udgivet: (2020)
• Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
  af: Luo, Jian, et al.
  Udgivet: (2016)
• Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
  af: Rhee, Chin Kook, et al.
  Udgivet: (2020)